Cantor Fitzgerald analyst Louise Chen reiterated a Neutral rating and $1.00 price target on TherapeuticsMD (NASDAQ: TXMD), following the company's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE